Condition: Bladder Cancer

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT06703476

Sponsor: Memorial Sloan Kettering Cancer Center

Phase: Phase 3

Eligibility:

• Age: minimum 21 Years maximum N/A
• Gender: All

Inclusion Criteria:

• Stent vs. no stent
• Patients aged ≥21 years who are scheduled to undergo radical cystectomy for treatment of bladder cancer with one of the consenting surgeons at MSK Alvimopan vs. no alvimopan
• Patients aged ≥21 years who are scheduled to undergo radical cystectomy for treatment of bladder cancer with one of the consenting surgeons at MSK Exclusion Criteria: Stent vs. no stent
• No

Exclusion Criteria:

• Stent vs. no stent
• No exclusion criteria Alvimopan vs. no alvimopan
• Patients on chronic opioid therapy are ineligible to receive alvimopan and will be excluded from this cohort of the trial

View trial on ClinicalTrials.gov